https://librepathology.org/w/index.php?action=history&feed=atom&title=Talk%3AAncillary_testing_in_prostate_cancer 2026-08-23T06:19:31Z Revision history for this page on the wiki MediaWiki 1.43.9 https://librepathology.org/w/index.php?title=Talk:Ancillary_testing_in_prostate_cancer&diff=52201&oldid=prev 2022-11-01T15:20:09Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 15:20, 1 November 2022</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Line 1:</td> <td colspan="2" class="diff-lineno">Line 1:</td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>MSI testing - in BRCA1/2: {{cite journal |<del style="font-weight: bold; text-decoration: none;">vauthors</del>=Barata P, Agarwal N, Nussenzveig R, Gerendash B, Jaeger E, Hatton W, Ledet E, Lewis B, Layton J, Babiker H, Bryce A, Garje R, Stein C, Kiedrowski L, Saylor P, Sartor O |title=Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA |journal=J Immunother Cancer |volume=8 |issue=2 |pages= |date=August 2020 |pmid= |pmc=7422632 |doi=10.1136/jitc-2020-001065 |url=}}</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>MSI testing - in BRCA1/2: {{cite journal |<ins style="font-weight: bold; text-decoration: none;">authors</ins>=Barata P, Agarwal N, Nussenzveig R, Gerendash B, Jaeger E, Hatton W, Ledet E, Lewis B, Layton J, Babiker H, Bryce A, Garje R, Stein C, Kiedrowski L, Saylor P, Sartor O |title=Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA |journal=J Immunother Cancer |volume=8 |issue=2 |pages= |date=August 2020 |pmid= |pmc=7422632 |doi=10.1136/jitc-2020-001065 |url=}}</div></td></tr> </table>

Michael https://librepathology.org/w/index.php?title=Talk:Ancillary_testing_in_prostate_cancer&diff=52199&oldid=prev 2022-11-01T15:17:10Z

<p>Created page with &quot;MSI testing - in BRCA1/2: {{cite journal |vauthors=Barata P, Agarwal N, Nussenzveig R, Gerendash B, Jaeger E, Hatton W, Ledet E, Lewis B, Layton J, Babiker H, Bryce A, Garje R...&quot;</p> <p><b>New page</b></p><div>MSI testing - in BRCA1/2: {{cite journal |vauthors=Barata P, Agarwal N, Nussenzveig R, Gerendash B, Jaeger E, Hatton W, Ledet E, Lewis B, Layton J, Babiker H, Bryce A, Garje R, Stein C, Kiedrowski L, Saylor P, Sartor O |title=Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA |journal=J Immunother Cancer |volume=8 |issue=2 |pages= |date=August 2020 |pmid= |pmc=7422632 |doi=10.1136/jitc-2020-001065 |url=}}</div>

Michael